Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran - BioLegacy Research

Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran

Post author:Sam
Post published:December 14, 2017
Post category:BioPharma

Clinical trial dosing will resume around year-end 2017.
Source: BioSpace